LUCENTIS solution for intravitreal injection 10mg/mL [macular edema following retinal vein occlusion, choroidal neovascularisation in pathologic myopia, diabetic macular edema] (ルセンティス硝子体内注射液10mg/mL[網膜静脈閉塞症に伴う黄斑浮腫、病的近視における脈絡膜新生血管、糖尿病黄斑浮腫])

País: Japó

Idioma: anglès

Font: すりの適正使用協議会 RAD-AR Council, Japan

Compra'l ara

ingredients actius:

Ranibizumab(genetical recombination)

Disponible des:

Novartis Pharma K.K.

Designació comuna internacional (DCI):

Ranibizumab(genetical recombination)

formulario farmacéutico:

injection

Informació per a l'usuari

                                Drug Information Sheet("Kusuri-no-Shiori")
Injection
Revised: 01/2023
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
LUCENTIS SOLUTION FOR INTRAVITREAL INJECTION
10MG/ML [MACULAR EDEMA FOLLOWING RETINAL
VEIN OCCLUSION, CHOROIDAL NEOVASCULARISATION
IN PATHOLOGIC MYOPIA, DIABETIC MACULAR
EDEMA]
ACTIVE INGREDIENT:
Ranibizumab(genetical recombination)
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine inhibits vascular endothelial growth factor (VEGF) which
is involved in leakage
of blood component from the retinal vessels or formation and growth of
choroidal neovascular
and reduces the amount of leakage to improve macular edema or causes
atrophy/loss of
choroidal neovascular. As a result, it improves failing vision.
It is usually used to treat macular edema following retinal vein
occlusion, choroidal
neovascularisation in pathologic myopia, diabetic macular edema.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have: ocular/periocular infections or suspected of them,
inflammation within the eye, a
history of stroke or transient ischemic attack.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         
         
                                
                                Llegiu el document complet
                                
                            

Cerqueu alertes relacionades amb aquest producte